Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5277-5280

  Lannutti, Brian J ^a   Gately, Stephen T ^a   Eugenia Quevedo, M ^a   Soff, Gerald A ^a   Paller, Amy S ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN;

ANEMIA; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; HEMANGIOENDOTHELIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; KASABACH MERRITT SYNDROME; METASTASIS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; TUMOR GROWTH; TUMOR VOLUME; VASCULAR TUMOR;

ANEMIA; ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMANS; MICE; MICE, NUDE; PEPTIDE FRAGMENTS; PLASMINOGEN; SPLEEN; SYNDROME; THROMBOCYTOPENIA;

EID: 0030692665     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
2. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
3. Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., and Soff, G. A. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor, angiostatin. Proc. Natl. Acad. Sci. USA, 94: 10868-10872, 1997.
4. Dong, Z., Kumar, R., Yang, X., and Fidler, I. J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88: 801-810, 1997.
5. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
6. Sim, B. K. L., O'Reilly, M. S., Liang, H., Fortier, A. H., He, W., Madsen, J. W., Lpacevich, R., and Nacy, C. A. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res., 57: 1329-1334, 1997.
7. Wu, Z., O'Reilly, M. S., Folkman, J., and Shing, Y. Suppression of tumor growth with recombinant murine angiostatin. Biochem. Biophys. Res. Commun., 236: 651-654, 1997.
8. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
9. Esterly, N. B. Kasabach-Merritt syndrome in infants. J. Am. Acad. Dermatol., 8: 504-513, 1983.
10. Hoak, J. C., Warner, E. D., Cheng, H. F., Fry, G. L., and Hankenson, R. R. Hemangioma with thrombocytopenia and microangiopathic anemia (Kasabach-Merritt syndrome): an animal model. J. Lab. Clin. Med., 77: 941-950, 1971.
11. Folkman, J., Haudenscild, C. C., and Zetter, B. R. Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. USA, 76: 5217-5221, 1979.
12. Gately, S., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L., Cundiff, D. L., Schnaper, H. W., Madison, L., Volper, O., Bouck, N., Enghild, J., Kwaan, H. C., and Soff, G. A. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res., 56: 4887-4890, 1996.
13. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem., 72: 248-254, 1976.
14. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
15. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
16. Enjolras, O., Wassef, M., Mazoyer, E., Frieden, I. J., Rieu, P. N., Drouet, L., Taieb, A., Stalder, J-F., and Escande, J-P. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J. Pediatr., 130: 631-640, 1997.
17. Ezekowitz, R. A. B., Mulliken, J. B., and Folkman, J. Interferon α-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med., 326: 1456-1463, 1992.
18. Chang, E., Boyd, A., Nelson, C. C., Crowley, D., Law, T., Keough, K. M., Folkman, J., Ezekowitz, R. A., and Castle, V. P. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J. Pediatr. Hematol. Oncol. 19: 237-244, 1997.
19. O'Reilly, M. S., Brem, H., and Folkman, J. Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470. J. Pediatr. Surg., 30: 325-330, 1995.